These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 130347)

  • 41. Treating drug problems.
    Gerstein DR; Lewin LS
    N Engl J Med; 1990 Sep; 323(12):844-8. PubMed ID: 2392142
    [No Abstract]   [Full Text] [Related]  

  • 42. A cost--benefit analysis for a multimodality heroin treatment project.
    Sirotnik KA; Bailey RC
    Int J Addict; 1975; 10(3):443-51. PubMed ID: 809366
    [No Abstract]   [Full Text] [Related]  

  • 43. Availability of activity reinforcers in a drug abuse clinic: a preliminary report.
    Yen S
    Psychol Rep; 1974 Jun; 34(3):1021-22. PubMed ID: 4846904
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug abuse: models of treatment and their consequences.
    Lief VF
    Int Pharmacopsychiatry; 1972; 7(1-4):7-21. PubMed ID: 4619399
    [No Abstract]   [Full Text] [Related]  

  • 45. Methadone vs. psychotherapy in the treatment of heroin addiction.
    Karkus HD
    Int J Addict; 1973; 8(3):427-34. PubMed ID: 4749900
    [No Abstract]   [Full Text] [Related]  

  • 46. Need conflicts of suburban narcotic abusers who apply to a county methadone maintenance program.
    Sheppard C; Ricca E; Fracchia J; Merlis S
    J Clin Psychol; 1975 Jan; 31(1):140-5. PubMed ID: 1112892
    [No Abstract]   [Full Text] [Related]  

  • 47. Proceedings: How can we compare the effectiveness of different programs and modalities?
    Barr HL
    Am J Drug Alcohol Abuse; 1976; 3(1):103-14. PubMed ID: 59543
    [No Abstract]   [Full Text] [Related]  

  • 48. A 20-year follow-up of New York narcotic addicts.
    Vaillant GE
    Arch Gen Psychiatry; 1973 Aug; 29(2):237-41. PubMed ID: 4741515
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of a large-scale narcotics treatment program: a six month experience.
    Brown BS; DuPont RL; Bass UF; Brewster GW; Glendinning ST; Kozel NJ; Meyers MB
    Int J Addict; 1973; 8(1):49-57. PubMed ID: 4713704
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug treatment programs in Pennsylvania. A statewide evaluation.
    Ball JC; Graff H
    Am J Public Health; 1975 Jun; 65(6):592-8. PubMed ID: 1093419
    [No Abstract]   [Full Text] [Related]  

  • 51. A revised treatment typology based on the DARP.
    Cole SG; James LR
    Am J Drug Alcohol Abuse; 1975; 2(1):37-49. PubMed ID: 1190193
    [No Abstract]   [Full Text] [Related]  

  • 52. Proceedings: Cost savings/benefit analysis of drug abuse treatment.
    Scanlon JC
    Am J Drug Alcohol Abuse; 1976; 3(1):95-101. PubMed ID: 820188
    [No Abstract]   [Full Text] [Related]  

  • 53. The impact of drug treatments on during-treatment criteria: 1971-1972 DARP admissions.
    Gorsuch RL
    Am J Drug Alcohol Abuse; 1975; 2(1):73-98. PubMed ID: 1190196
    [No Abstract]   [Full Text] [Related]  

  • 54. Cost-benefit analysis: a research tool for evaluating innovative health programs.
    Bootman JL; Rowland C; Wertheimer AI
    Eval Health Prof; 1979 Jun; 2(2):129-54. PubMed ID: 10308892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of treatment outcomes in a drug abuse rehabilitation network: Newark, New Jersey.
    Sheffet AM; Quinones MA; Doyle KM; Lavenhar MA; Nakah AE; Louria DB
    Am J Drug Alcohol Abuse; 1980; 7(2):141-73. PubMed ID: 7446508
    [No Abstract]   [Full Text] [Related]  

  • 56. The methadone method.
    Whyman JS; Woody GE; Patch VD
    N Engl J Med; 1972 Mar; 286(13):728-9. PubMed ID: 5061064
    [No Abstract]   [Full Text] [Related]  

  • 57. Attitudes toward drug abuse among residents in a therapeutic community.
    Hart L
    Int J Addict; 1973; 8(5):809-20. PubMed ID: 4781418
    [No Abstract]   [Full Text] [Related]  

  • 58. Health insurance for drug addiction: a survey.
    Muller C
    Am J Psychiatry; 1972 Jun; 128(12):1516-23. PubMed ID: 5025272
    [No Abstract]   [Full Text] [Related]  

  • 59. Federal drug abuse policy and minority group issues--reflections of a participant-observer.
    Brown BS
    Int J Addict; 1985 Jan; 20(1):203-15. PubMed ID: 3888861
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug abuse treatment.
    Phillipson R
    J Sch Health; 1972 Dec; 42(10):625-8. PubMed ID: 4485227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.